CD14 (MY4, mIgG1), FITC-conjugated IgG1 and FITC-conju-
gated IgG2b were obtained from Coulter (Hialeah, FL, USA). Anti-CD69 (TP1/55.3.1, mIgG2b), anti-CD32 (2E.1, mIgG2a), FITC-conjugated anti-HLA-DR class II (B8.12.2, mIgG2b), FITC-conjugated anti-CD11b (Mac-1, BEAR1, mIgG1), goat Introduction F(abЈ)2 fragment anti-mouse FITC-conjugated Ig and mIgG1 (679.1 Mc7) were purchased from Immunotech (Luminy, Within the immunoglobulin (Ig) superfamily, three distinct France). Mouse FITC-conjugated anti-CD16 (Fc␥RIII, 3G8, classes of cell surface receptors binding the Fc region of IgGs mIgG1), FITC-conjugated anti-CD32 (Fc␥RII, IV.3, mIgG1), have been identified on human leukocytes. 1, 2 Fc␥RI (CD64), FITC-conjugated anti-CD64 (Fc␥RI, 32.2, mIgG1) and antipresent on monocytes, macrophages, activated neutrophils CD32 (IV.3) were obtained from Medarex (Annandale, NJ, and leukemia cell lines, binds with high affinity, monomeric USA). Human IgGs (IgG1, IgG2) were purchased from Serotec human IgG and murine IgG2a and IgG3 subclasses. [1] [2] [3] Fc␥RII (Oxford, UK). Ficoll-Hypaque, Protein G-Sepharose and (CD32) is broadly distributed and binds IgG with low affinity Limulus amoebocyte assay were purchased from Pharmacia (human IgG and murine IgG1, 2a and 2b) in complexed or (Uppsala, Sweden). Immobilized pepsin was purchased from polymeric form. [1] [2] [3] [4] cDNA analysis has revealed the existence Bio-Rad (Hercules, CA, USA). of at least six Fc␥RII isoforms whose exact cell type distribution is, however, still unclear. 1, 2, 4 The third class (CD16) includes two isoforms, Fc␥RIIIa expressed on macrophages, Cells and cell culture natural killer cells and some monocytes and T cells, 1, 2 and Fc␥RIIIb selectively expressed on granulocytes.
1,2 Both Fc␥RIII HL-60 and U937 cell lines (mycoplasma-free tested) were isoforms interact with low affinity, with complexed as well as maintained in RPMI 1640 medium supplemented with 5% monomeric IgG (human IgG1 and 3, murine IgG3). 1, 2 heat-inactivated fetal calf serum (FCS; Gibco, Paisley, UK, LPS levels Ͻ0.1 ng/ml), 2 mM L-glutamine, 1 arrest of leukemia HL-60 and U937 cells
The effects of mIgG1, mIgG2a, mIgG2b and mIgM (Coulter Cytokine production source) were investigated on HL-60 and U937 cell prolifer- erlo, Belgium). Figure 1 , mIgG1 and mIgG2b blocked HL-60 and U937 cell proliferation (50 to towards macrophages 80% inhibition) whereas mIgG2a and mIgM did not significantly alter cell growth, indicating that the phenomenon was At day 5, the block in growth of mIgG1-or mIgG2b-treated subclass specific. Growth inhibition of U937 cells by mIgG1 leukemia cell lines was correlated with a marked enhanced was observed within the range of concentrations of 1 to expression of the cell surface activation antigen CD69 (data 20 g/ml mIgG1 ( Figure 2a ) and already after 2 days of treatnot shown) and the cell surface maturation Mac-1/CD11b ment ( Figure 2b ). Of note, block in cell growth could also be ( Figure 3 , increase in percentage and density), whereas no sigachieved with a mIgG1 from another commercial source nificant modification in HLA-DR class II expression was (Immunotech) and mIgG preparations contained no detectable observed ( Figure 3 ). In contrast, mIgG2a and mIgM did not LPS (Ͻ0.03 U/ml) as determined by the Limulus amoebocyte have any effect on Mac-1/CD11b expression (data not shown). assay, thus ascertaining the mIgG1/mIgG2b specificity in cell
In parallel, a change in morphology (decrease in the growth arrest.
nuclear/cytoplasmic ratio and apparition of vacuolization) consistent with partial macrophage differentiation was observed in cells exposed to mIgG1 (Figure 4b Human IgG1 and IgG2 molecules induce differentiation of leukemia HL-60 and U937 cells towards macrophages
Culture of HL-60 and U937 cells in the absence or in the presence of increasing concentrations of human (h) IgG1 (1 to 20 g/ml), caused a significant inhibitory effect on cell pro- Supernatants from untreated or mIgG1-treated monocytes and leukemia U937 cells were assayed for IL-1␤, IL-6, IL-10, GMEffects of F(abЈ)2 fragments of mIgG1 and anti-CD32 mAbs on leukemia cell growth CSF, TGF-␤ and TNF-␣ production. Up to 5 days, no detectable levels of IL-1␤, IL-10, GM-CSF and TNF-␣ were measured in supernatants from U937 cells before and after stimu-A preparation enriched in F(abЈ)2 fragments of mIgG1 (р20% contaminant mIgG1) was not as efficient as the intact mollation with mIgG1 (data not shown). However, very low levels of IL-6 were detected in the cultures of unstimulated and ecule in inhibiting leukemia cell growth (Table 3a) thus suggesting a requirement for the antibody Fc region for inducing mIgG1-stimulated U937 cells (Figure 7a , Ͻ15 pg/ml at day 5). In contrast, untreated U937 cells produced low but detectable an inhibitory growth effect. In the next experiments, we blockaded the IgG Fc portion binding site of Fc␥RII (CD32) present amounts of latent TGF-␤ and mIgG1 significantly increased these levels (four-fold increase) (Figure 7a ). Purified monoon both cell lines with mAbs IV.3 and 2E.1. Of note, mAb IV.3 was previously reported to be a neutralizing mAb by cytes cultured for 2 days in the absence or in the presence of mIgG1, produced no detectable amounts of TNF-␣ and TGFblocking the binding activity of Fc␥RII on reactive cells.
12 Culture of leukemia cells in the presence of mAbs IV.3 or 2E. 1 ␤, or detectable levels of GM-CSF (Ͻ30 pg/ml) and IL-10 (Ͻ220 pg/ml) (data not shown). More importantly, monocytes (when compared to their respective isotype-matched control Abs mIgG2b or mIgG2a) instead slightly increased cell proreleased higher levels of IL-1␤ (800 pg/ml) and IL-6 (6000 pg/ml) ( Figure 7b ) and mIgG1 was capable of markedly liferation (Table 3B ). When coincubated with mIgG1 and leukemia cells, mAbs 2E.1 and IV.3 showed competition with enhancing the release of these cytokines (Figure 7b , three-to five-fold increase, respectively). Of note, mIgG2b was also mIgG1 in preventing cell growth arrest induced by mIgG1, with mAb IV.3 more effective than mAb 2E.1 (Table 3B) .
capable of enhancing IL-1␤ and IL-6 release by monocytes (data not shown). In parallel, the effects of mIgG1 on IL-1␤ and IL-6 mRNA expression was evaluated by Northern blot. Spontaneously activated monocytes expressed detectable levMouse IgG1 potentiates spontaneous monocyte activation and maturation els of IL-1␤ mRNA (1.3 kb) and IL-6 mRNA (1.8 kb) (Figure 8 ) and treatment with mIgG1 for 24 h increased mRNAs for both IL-1␤ (three-fold enrichment factor normalized for actin In the absence of any stimulus, it is known that isolated monocytes cultured in vitro for several days spontaneously activate transcripts) and IL-6 (two-fold enrichment factor) ( Figure 8 ). and differentiate into macrophages. 13 Here, treatment of purified blood monocytes with 20 g/ml mIgG1 or mIgG2b induced more pronounced morphological changes characterDiscussion istic of macrophage activation in the first 48 h incubation (apparition of lysosomal vacuoles) as compared to monocytes It was previously demonstrated that IgG2a molecules promoted maturation of murine bone marrow macrophages. 5 cultured in medium (data not shown). This was accompanied by an enhancing effect of both mIgGs on HLA-DR class II Whether Ig molecules exerted a similar effect on human monocytic lineage cells was unknown. In this study, we show that ( Figure 6 ) whereas Mac-1/CD11b expression was less affected ( Figure 6) . treatment of leukemia HL-60 and U937 cells with mIgG1 led
Figure 4
Light microscopic morphology of leukemia HL-60 and U937 cells exposed to mIgG1, 2a or 2b. HL-60 (a-d) or U937 (e-h) cells were cultured for 5 days in the absence (a, e) or in the presence of 20 g/ml mIgG1 (b, f), mIgG2a (c, g) or mIgG2b (d, h) as described in the Methods. Original magnification ×600. May-Grü nwald stain. Scale bar, 10 m.
to a dose-and time-dependent inhibitory growth effect. This shift towards a macrophage morphology associated with the enhanced expression of the cell surface maturation antigen effect was almost lost upon removal of the Fc parts of mIgG1, suggesting the requirement for mIgG1 to have an intact Fc Mac-1/CD11b. Similarly, mIgG2b, but not mIgG2a nor mIgM, induced block in growth and induction of differentiation of portion to transduce a signal resulting in cell growth arrest. with certain proteolytic enzymes 1, 18 and be decreased by serine protease inhibitors. 1, 19 Myeloid cell lines, monocytes and In agreement with these observations, we recently found that leukemia cells stimulated for 5 days by mIgG1, released higher levels of cathepsin G (300 nmol/30 min/10 5   Table 3 Effects signaling pathway leading to formation of inositol (1, 3, 4, 5, 6) A. Leukemia cells were cultured in RPMI 1640 plus FCS in the P5 and inositol P6. 21 Interestingly, these molecules may be absence (control) or in the presence of 20 g/ml intact mIgG1 or involved in the mechanism of differentiation of monocyte/ TGF-␤ at low levels (Ͻ1 ng/ml) whereas we observed or mIgG2a, 20 g/ml) or combinations of anti-CD32 and mIgG1
enhanced IL-1␤ (Ͼ2 ng/ml) and IL-6 (Ͼ30 ng/ml) release in (20 g/ml and 10 g/ml, respectively) and cell proliferation in the the extracellular medium accompanied by augmented IL-1␤
presence of specific antibodies was corrected for cell effect by the and IL-6 transcript levels in mIgG1-treated monocytes. Our IL-1 and IL-6 secretion. [23] [24] [25] A more recent study indicated that IL-6 production was triggered by cross-linking of Fc␥RIIA HR with specific mIgG1 isotype Abs, 26 thus reinforcing our data.
Figure 6
Representative histograms demonstrating the effect of mIgG1 and mIgG2b on the expression of CD11b and HLA-DR class II on monocytes. Human monocytes isolated from blood (1 × 10 6 /ml) were cultured for 1 day in RPMI 1640 plus 10% FCS in the absence or in the presence of 20 g/ml of mIgG1 or mIgG2b. Specific fluorescence intensities of CD11b and HLA-DR antigens (black line) were detected by direct immunofluorescence in a Becton flow cytometer as described in Materials and methods. Staining of cells with a matched isotype antibody served as the respective negative control (thin line). Results are expressed as relative cell number (y-axis) vs log fluorescence intensity (x-axis).
Values represent % positive cells (MFI).

Figure 8
Cytokine mRNA expression in isolated blood monocytes treated with mIgG1. Total mRNA from isolated monocytes cultured for 24 h in the absence or in the presence of 20 g/ml mIgG1 were prepared as described in the Methods. Northern blots of total RNA were hybridized with 32 P IL-1␤, IL-6 or ␤-actin cDNAs. Quantification of mRNA bands was performed using the PhosphorImager system (Molecular Dynamics, Sunnyvale, CA, USA).
Another study showed that TNF-␣ secretion by monocytes can only be induced by mIgG2a cross-linking of Fc␥RI 23 and we 
